4
Changes in Ownership
IRulya Therapeutics Inc. Filed Acc 0001209191-22-031508
Chief Medical Officer acquired 24,336 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Smith Karen L. · Chief Medical Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-05-19 | Grant or award : show line 1 in the form | +24,336 | 24,336 | D |
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-05-19 | Grant or award : show line 2 in the form Employee Stock Option (right to buy) | +151,799 | 151,799 | D |
| 2022-05-23 | Grant or award : show line 3 in the form Employee Stock Option (right to buy) | +1,365,449 | 1,365,449 | D |
Loading xslF345X03/doc4.xml…